Last close As at 14/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Financials
In its H123 results, Secure Trust Bank (STB) delivered an 11% y o y increase in operating income, overcoming margin pressure on rising interest rates. However, PBT was £16.5m, 4% lower than in H122 as the bank incurred a one-off impairment charge of £7.0m stemming from a long-standing debt case in Commercial Finance. Excluding this charge, PBT was £23.5m, which implies a 6% beat on our estimates on an annualised basis. Across the group, underlying impairments are resilient, especially in Vehicle Finance where impairments fell to 2.4% (H122: 8.0%) as lending shifted to prime borrowers. We have increased our FY23 and FY24 continuing PBT forecasts to £45m and £55m respectively, leaving the stock trading at P/E ratios of only 4.0x in FY23 and 3.1x in FY24.
Written by
Secure Trust Bank |
One-off impairment masks underlying PBT beat |
H123 results |
Banks |
4 September 2023 |
Share price performance
Business description
Next events
Analysts
Secure Trust Bank is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
In its H123 results, Secure Trust Bank (STB) delivered an 11% yoy increase in operating income, overcoming margin pressure on rising interest rates. However, PBT was £16.5m, 4% lower than in H122 as the bank incurred a one-off impairment charge of £7.0m stemming from a long-standing debt case in Commercial Finance. Excluding this charge, PBT was £23.5m, which implies a 6% beat on our estimates on an annualised basis. Across the group, underlying impairments are resilient, especially in Vehicle Finance where impairments fell to 2.4% (H122: 8.0%) as lending shifted to prime borrowers. We have increased our FY23 and FY24 continuing PBT forecasts to £45m and £55m respectively, leaving the stock trading at P/E ratios of only 4.0x in FY23 and 3.1x in FY24.
Year end |
Operating income (£m) |
PBT* |
EPS** |
DPS |
P/E |
Yield |
12/21 |
148.9 |
55.9 |
239.4 |
61.1 |
2.8 |
9.2 |
12/22 |
169.6 |
39.0 |
174.7 |
45.1 |
3.8 |
6.8 |
12/23e |
188.5 |
45.0 |
168.0 |
42.0 |
4.0 |
6.3 |
12/24e |
221.8 |
55.0 |
214.9 |
53.7 |
3.1 |
8.1 |
Note: *PBT from continuing operations. **Fully diluted.
Record new business lending
Lending balances in H123 reached £3.2bn, a sizeable 15% uplift from the £2.8bn reported in H122. Record new business lending of £1.15bn underpinned growth in H123 (H122: £1.12bn). Growth was mainly driven by Consumer Finance (made up of Vehicle Finance and Retail Finance) as STB continued to focus on increasing its exposure to prime, higher credit quality lending. Despite interest rates putting pressure on the real estate market, Real Estate Finance lending was robust, with loan balances growing by 7% over H122. New business dramatically slowed in Commercial Finance as interest rates began to affect small and medium-sized enterprises (SMEs). Earnings per share fell to 59.4p (H122: 102.4p) and a dividend of 16.0p/share was declared (H122: 16.0p).
PBT estimates raised for both FY23 and FY24
Although the macroeconomic climate is a challenge, management remains optimistic in its ability to monetise efficiency initiatives, keep impairments stable, drive lending growth and improve profitability in H223 and FY24. On promising H123 results and management’s confident outlook, we have increased our continuing PBT forecasts to £45m in FY23 and £55m in FY24.
Valuation: Undervalued based on peer comparison
On our FY23 estimates, STB is trading at a diluted price to book value (P/BV) of 0.36x and a P/E of only 4.0x. Based on peer valuation multiples, the bank should be trading closer to c 0.6x P/BV or c 1,000p/share, which implies an upside of c 50%. Management targets a return on equity of 14–16% and lending book growth of 15% per year in the medium term. Contingent on achieving these targets, STB should trade closer to book value.
H123 results analysis
The shift towards focusing on prime and near-prime products, as well as growing its distribution network, has enabled STB to drive strong originations and grow lending balances while keeping arrears at subdued levels.
In H123, STB grew its total lending balances by 15% compared to H122 (see Exhibit 1). New business in Commercial Finance slowed down significantly despite lending balances being up from H122, as we enter an elevated interest rate environment that is curbing business activity. The group recognised a £7.0m impairment charge, which originated from a long-standing debt issue. On the earnings call, management reassured investors that there are no other similar cases in the current loan book. Overall, PBT was 4% lower than in H122 at £16.5m. Excluding the impairment charge, it would have been £23.5m. On an annualised basis, this implies PBT would be £47m in FY23, 6% above our previous estimate.
Consumer Finance
In Retail Finance, new business grew 14.7% to £614m compared to H122, while lending balances increased 28.8% to £1,180m and generated revenues of £49.2m in H123 versus £35.9m in H122. Growth was underpinned by interest free products in furniture and jewellery, which attracts lower-risk customers but at lower net interest margins. Interest free lending now accounts for 86.2% of the lending book (FY22: 85.1%). The shift to prime lending has also allowed the group to keep impairments at stable levels even as lending continues to grow. Cost of risk for the period was 1.6% versus 1.4% in H122. Arrears for Retail Finance continues to remain low at 0.8%.
Additionally, AppToPay was introduced to a number of select retailers, which has marked STB’s entrance into the buy now, pay later (BNPL) market, where it expects to grow its market share. The app has been fully integrated into the suite of products offered by Retail Finance so it requires no IT integration by its retail partners. The group continues to leverage its retailer network to drive growth, which now stands at over 1,400 partnerships.
Vehicle Finance generated £250m in new business lending, up 41.7% in H122, achieving lending balances of £440m, an increase of 32.4% versus this time last year. As a result, the division generated a 30% increase in revenues to £29.0m.
Having tightened credit standards in 2022 and increased its prime lending activities, the cost of risk fell dramatically to 2.4% compared to 8.0% in H122. IFRS 9 provisioning was also a factor as the strong volume growth last year required upfront reserving. Arrears for near prime lending continue to be stable and has trended downwards towards 12.4% (FY22: 14.4%), while total arrears for vehicle finance – near prime and prime combined – dropped to 10% from 12.2% at the end of December. We highlight that the shift to more prime lending has resulted in lower net revenue margins to 11.4% compared to 12.9% in H122.
In common with its Retail Finance division, Vehicle Finance has a strong dealer network, which has increased from 560 in FY22 to 680 at H123.
Business Finance
In Real Estate Finance, new business lending was £252m, a modest 4.4% increase from H122. Lending balances grew respectably by 6.9% to £1,222m. but revenues jumped 30% to £35.1m on higher lending margins as STB is beginning to reprice the book against a headwind of rising UK interest rates. By the end of H123, 82% of the loan book was comprised of residential investment financing (FY22: 85%). With an average loan-to-value (LTV) ratio of 56.4%, the bank retains a good cushion against credit loss even if defaults rise should the economy weaken significantly.
Modelling provisions under IFRS 9, STB has increased its provisioning in stage 3 loans to £3.6m (H122: £2.2m). Consequently, impairment charges increased to £2.2m (H122: £0.2m) resulting in cost of risk rising to 0.4% from 0.0% in H122.
In Commercial Finance, rising interest rates, increasing cost pressures and slowing activity have affected volumes in the SME market. New business lending experienced a significant decline in comparison with H122, falling to £31.4m from £136m – a 76.9% decrease. Lending balances decreased at a slower rate to £316m from £360m in H122. However, total revenues increased 45.6% to £18m as revenue margins increased to 7.3% from 5.9% in H122. The rising yield is a result of the lagged effect of the bank passing previous interest rate rises (which had initially squeezed margins) onto borrowers. We also note that lending balances from the government Coronavirus Business Interruption Loan Scheme, Coronavirus Larger Business Interruption Loan Scheme and Recovery Loan Scheme are now running off, with the loan schemes totalling only £20m (FY22: £29m). This exposure has always been very low at STB and speaks to the company’s strong risk management culture.
In the half, the group took an impairment charge of £7.0m mainly related to a material loss of £7.2m on a long-running debt case that had not been previously included in Stage 3 loans in expectation of sufficient recovery. Management highlighted that this was a unique occurrence, and it does not expect such events to occur within the current lending book. Consequently, impairment charges for Commercial Finance increased to 4.1% (H122: 0.0%). Excluding the unique impairment charge, total write offs between 2015 and 2023 have been only 0.04% of average lending balances. Including the £7.2m charge, the average charge over the same period would still only be 0.6%.
Below, Exhibit 1 summarises the lending and impairment performance explained in the text above.
Exhibit 1: Loan and impairment analysis – H123 versus H122
(£m unless stated otherwise) |
H122 |
H123 |
Change* |
Real Estate Finance |
1,142.6 |
1,221.8 |
6.9% |
Commercial Finance |
359.8 |
316.4 |
(12.1%) |
Business Finance |
1,502.4 |
1,538.2 |
2.4% |
Retail Finance |
916.2 |
1,179.9 |
28.8% |
Vehicle Finance |
332.6 |
440.4 |
32.4% |
Consumer Finance |
1,248.8 |
1,620.3 |
29.7% |
Total lending balance |
2,751.2 |
3,158.5 |
14.8% |
Impairments |
|||
Real Estate Finance |
0.0% |
0.4% |
0.4pp |
Commercial Finance |
0.0% |
4.1% |
4.1pp |
Business Finance |
0.0% |
1.2% |
1.2pp |
Retail Finance |
1.4% |
1.6% |
0.2pp |
Vehicle Finance |
8.0% |
2.4% |
(5.6)pp |
Consumer Finance |
3.2% |
1.8% |
(1.4)pp |
Total impairments |
1.3% |
1.5% |
0.2pp |
Source: Secure Trust Bank, Edison Investment Research
Profit and loss analysis
On the back of increased lending balances and previous interest rate rises, the bank generated interest income of £139m, up 53% from H122 (see Exhibit 2). Interest expenses, however, grew at a much steeper rate to £57.8m from £17.5m as the bank passed on higher rates to savers and also bore the costs of the £90m Tier 2 callable bond it issued earlier in the year. The bond pays a 13% fixed coupon and matures in August 2033. The bond issuance impacted the net interest margin by 20bp, but provides capital to facilitate growth in the business. Despite interest expense pressure, operating income grew 11% from H122 to £89.1m.
Operating expenses increased 9.7% to £50.7m from £47.0m in H122, broadly in line with the rate of inflation. STB continues to work on its cost efficiency programme, Project Fusion, which is on track to deliver c £4m in annualised savings by the end of the year and had achieved £2m in H123. The bank aims for a cost income ratio of less than 50% in the medium term. In H123 the cost income ratio was 56.9% and we forecast 54% at the end of FY23 including the remainder of Project Fusion which will fully annualise in 2024.
The one-off £7.0m charge in Commercial Finance mentioned earlier took impairments to £23m in the half, 28% larger than in H122. Excluding the charge, impairments would have been £16.0m, 11% lower than H122 despite a higher lending balance – a product of focusing on prime, higher credit quality consumers. The one-off charge increased group cost of risk to 1.5% (H122: 1.3%).
PBT was £16.5m, slightly below the £17.1m reported in H122. Stripping out the impairment charge, PBT would have been £23.5m. Annualising this, the bank would be on track for £47m in FY23, 6% above our previous estimate of £44.4m.
As expected, the bank also recognised a £1.5m loss associated with the disposal of the Debt Managers Services business. A further final c £0.5m loss is expected in the year.
Profit for the year was reported 42% lower than H122 at £11.1m. We do highlight that in H122, the group benefited from an initial profit of £6.1m from the disposal of Debt Managers Services, which influenced the bottom line. As a result, earnings per share was 42% lower at 59.4p/share (H122: 102.4p/share).
The board has approved an interim dividend of 16p/share, in line with H122 and representing a payout ratio of 27%, to be paid on 28 September 2023. In the outlook, management states it is optimistic that profitability will improve strongly in the second half of the year and into FY24.
Exhibit 2: Profit and loss account
(£m unless stated otherwise) |
H122 |
H222 |
H123 |
H123 vs H122 |
Interest income |
90.6 |
112.4 |
138.8 |
53% |
Interest expense |
(17.5) |
(32.9) |
(57.8) |
230% |
Net interest income |
73.1 |
79.5 |
81.0 |
11% |
Fee & commission income |
8.1 |
9.3 |
8.1 |
0% |
Fee & commission expense |
(0.2) |
(0.2) |
0.0 |
(100%) |
Operating income |
81.0 |
88.6 |
89.1 |
11% |
Operating expenses |
(46.2) |
(47.0) |
(50.7) |
10% |
Impairment charges on loans |
(17.9) |
(20.3) |
(23.0) |
28% |
Gains on modification of financial assets |
0.7 |
0.4 |
0.2 |
(71%) |
Fair value gains/(losses) on financial instruments |
(0.5) |
0.2 |
0.9 |
(280%) |
Other income/(losses) |
0.0 |
0.0 |
0.9 |
|
Profit before income tax from continuing operations |
17.1 |
21.9 |
16.5 |
(4%) |
Income tax expense |
(4.2) |
(5.2) |
(4.2) |
0% |
Profit for the year from continuing operations |
12.9 |
16.7 |
12.3 |
(5%) |
Profit for the year from discontinued operations |
7.6 |
(2.6) |
(1.5) |
(120%) |
Tax on discontinued operations |
(1.4) |
0.5 |
0.3 |
(121%) |
Profit for the year |
19.1 |
14.6 |
11.1 |
(42%) |
Earnings per share (p) |
102.4 |
78.1 |
59.4 |
(42%) |
Diluted earnings per share (p) |
99.1 |
75.6 |
57.9 |
(42%) |
Dividend per share (p) |
16.0 |
29.1 |
16.0 |
0% |
Key ratios |
||||
Common equity tier 1 (CET1) ratio |
14.0% |
14.0% |
13.0% |
|
Return on equity (ROE) |
12.5% |
9.0% |
6.8% |
|
Net interest margin (NIM) |
5.7% |
5.7% |
5.4% |
|
Cost to income ratio (CIR) |
57.0% |
53.0% |
56.9% |
Source: Secure Trust Bank, Edison Investment Research
Estimates upgraded
Loan and impairment forecasts
We have significantly increased our lending estimates for both Vehicle and Retail Finance. For Vehicle Finance, reported lending balances in H123 were £440m, 5% higher than our FY23 estimate of £420m. Since demand for vehicles (and vehicle finance) continues to be elevated, and STB’s distribution network has grown, we have increased our estimates by 19% and 28% for FY23 and FY24, respectively. Similarly, Retail Finance lending was strong in H123, with lending balances of £1.2bn and already reaching our FY23 estimate of £1.2bn. As the bank expands its interest free lending operations and continues to leverage its retail network and grow market share, we expect that lending growth will be strong throughout the rest of FY23 and into FY24. Therefore, we have increased our lending balance estimates by 7% and 10% for FY23 and FY24.
After robust lending in H123 in Real Estate Finance, we have increased our lending balances by 7% in FY23 and 5% in FY24. We expect this trend to continue into the second half, but looking ahead we anticipate paydowns on loans to increase given indicators of forward inflation and interest rates so have conservatively kept balances flat in FY24.
On the other hand, Commercial Finance lending slowed down in H123 and the group remains focused on managing its existing customer base effectively. In anticipation of a continuing difficult environment for SMEs, we have taken into account the weaker H123 volumes and erred on the cautious side in our estimates for commercial lending. Therefore, we have lowered our lending balance estimates for FY23 and FY24 by 10% and 9% respectively in Commercial Finance.
Consequently, our estimates for total balances in FY23 and FY24 have risen to £3.4bn and £3.7bn for FY23 and FY24, increases of 6% and 8% from our previous estimates of £3.2bn and £3.5bn. We have provided a summary of our lending balance estimates in Exhibit 3 below.
Exhibit 3: Lending balance estimates
£m |
Previous FY23e |
Previous FY24e |
New |
New |
Change in FY23e |
Change in FY24e |
Real Estate Finance |
1,140 |
1,165 |
1,220 |
1,220 |
7.0% |
4.7% |
Commercial Finance |
400 |
440 |
360 |
400 |
(10.0%) |
(9.1%) |
Business Finance |
1,540 |
1,605 |
1,580 |
1,620 |
2.6% |
0.9% |
Vehicle Finance |
420 |
490 |
500 |
625 |
19.0% |
27.6% |
Retail Finance |
1,220 |
1,360 |
1,300 |
1,500 |
6.6% |
10.3% |
Consumer Finance |
1,640 |
1,850 |
1,800 |
2,125 |
9.8% |
14.9% |
Total |
3,180 |
3,455 |
3,380 |
3,745 |
6.3% |
8.4% |
Source: Edison Investment Research
Credit quality within the total loan book continues to be robust. Although the one-off charge in Commercial Finance materially affected profitability, management reiterated that it was a unique occurrence and is confident that no other situations are present in the current loan book. Additionally, despite market interest rate increases, the Real Estate Finance division, has only witnessed a very small number of clients in an active workout situation. STB can also work with customers on agreeing revisions to interest cover covenants, where deemed appropriate.
Moreover, in Vehicle and Retail Finance, impairments and arrears continue to be stable. Arrears in Retail Finance were stable at 0.8% (FY22: 0.8%) while the percentage of arrears in Vehicle Finance have reduced materially since FY22. In the near prime book, arrears dropped to12.4% from 14.4% in FY22, with total arrears in the Vehicle loan book falling to 10.0% from 12.2% in FY22.
In our estimates for the consolidated group in FY23, we have held impairments at 1.4% (see Exhibit 4). We have increased Real Estate impairments by 0.2 percentage points in FY23 to reflect the increase in impairments recorded in H123 but have left our FY24 estimate unchanged. In Commercial Finance, our impairment estimate is now 2.2% as we reflect the one-off impairment charge recorded in H123. Vehicle Finance impairments were particularly robust in H123, so we have reduced our impairment estimates for FY23 and FY24 by 3.1 and 1.1 percentage points, respectively. As the Vehicle loan book continues to incorporate more prime lending, we expect impairment levels in the segment to remain resilient. In Retail Finance, impairments were 1.6%, in line with our full year expectations. We expect impairment here to remain broadly stable with a slight increase of 0.1% in 2024.
In absolute terms, total impairments for FY23 are now reduced marginally by 3.7% to £42.8m because of the downward revision in Vehicle Finance, whereas we forecast an increase of 6.5% in FY24 to £51.5m as we have assumed a higher overall loan book than previously estimated.
Exhibit 4: Loan impairments estimate changes
Old FY23e |
Old FY24e |
New FY23e |
New FY24e |
Change in FY23e* (pp) |
Change in FY24e* (pp) |
|
Real Estate Finance |
0.2% |
0.2% |
0.4% |
0.2% |
0.2 |
0.0 |
Commercial Finance |
0.3% |
0.3% |
2.2% |
0.3% |
1.9 |
0.1 |
Vehicle Finance |
5.8% |
5.6% |
2.8% |
4.5% |
(3.1) |
(1.1) |
Retail Finance |
1.6% |
1.6% |
1.6% |
1.7% |
(0.1) |
0.1 |
Total loan impairments |
1.4% |
1.4% |
1.4% |
1.4% |
0.0 |
0.0 |
Impairments (£m) |
44.5 |
48.4 |
42.8 |
51.5 |
(3.7%) |
6.5% |
Source: Edison Investment Research. Note: *Measured in percentage points excluding impairments calculation.
Financial estimates
Despite lower earnings because of the one-off charge and the headwind in FY23 interest expense from cost of the Tier 2 bond issuance, the outlook for STB is positive into H223. Lending growth remains strong and yields earned on loans should rise notwithstanding the shift to prime lending as rate increases are increasingly passed through to borrowers. Impairments continue to be stable and cost saving initiatives such as Project Fusion should be tailwinds to stronger profitability.
Following the upward revisions to our lending balance estimates, our forecasts for both FY23 and FY24 have increased (see Exhibit 5). We have increased our continuing PBT estimate by 1.2% in FY23 despite the H123 miss (due to the one-off impairment charge). Had the charge not occurred, annualised PBT would be £47m, above both our old and new estimates. We expect PBT growth to accelerate into the second half of the year with net interest margin expanding to 5.5% from 5.3% in H1. In FY24, we anticipate 11% lending growth, broadly stable impairment (on the continuing shift towards more prime lending) and an expanding net interest margin to 5.7% as the book reprices and the mix shifts towards higher rate Consumer Finance. Consequently, we have increased our FY24 operating income forecast by 8.3% to £221.8m.
Management reiterated its plans to reduce the cost income ratio and maintain good margins. Against an inflationary backdrop, the cost income ratio only moved up 1bp to 56.9% in H123 (H122: 57.0%). Alongside this, the bank is also expecting to deliver on the c £4m in annualised savings in the year from Project Fusion, having delivered half of this on a run-rate basis in H123. Taking everything into account, we have forecast a 5.7% increase in continuing PBT: we anticipate the cost income ratio to continue improving (we forecast 54% in FY23 and 52% in FY24) and net interest margin to gradually increase to 5.4% in FY23 and 5.7% in FY24, resulting from a higher weighting towards the Consumer Finance book and previous interest rate rises being passed through to loan yields.
Exhibit 5: Estimate changes
FY23e |
FY24e |
|||||
Old |
New |
Change |
Old |
New |
Change |
|
Operating income (£m) |
189.3 |
188.5 |
(0.4%) |
204.8 |
221.8 |
8.3% |
Continuing PBT (£m) |
44.4 |
45.0 |
1.3% |
52.0 |
55.0 |
5.7% |
Diluted EPS (p) |
167.0 |
168.0 |
0.6% |
200.1 |
214.9 |
7.4% |
DPS (p) |
41.7 |
42.0 |
0.6% |
50.0 |
53.8 |
7.4% |
Source: Edison Investment Research
Valuation
In Exhibit 6 we compare STB to a peer group of mid-sized / specialist lenders in the UK. We observe that, on a calendarized basis, STB trades at a significantly lower 2023 P/E ratio despite having a competitive return on equity (ROE). Additionally, in 2024, with an ROE only 1.2 percentage points lower than the peer average, STB trades at a P/E ratio 48% below the average. Alongside this, STB offers a good current dividend yield of 6.3%, but is below the average of 8.1% as it is retaining more capital for growth.
Exhibit 6: Peer group table
Price |
Market |
P/E CY23e (x) |
P/E CY24e (x) |
ROE CY23e (%) |
ROE CY24e (%) |
Dividend yield (%) |
||
Close Brothers |
822 |
1,237 |
N/A |
7.0 |
7.3 |
10.9 |
8.0 |
|
Virgin Money |
163 |
2,216 |
5.3 |
4.8 |
7.3 |
8.0 |
6.1 |
|
Metrobank |
103 |
178 |
16.5 |
9.4 |
1.8 |
2.7 |
N/A |
|
OneSavings Bank |
342 |
1,362 |
4.7 |
3.4 |
15.6 |
19.9 |
8.9 |
|
Paragon |
523 |
1,144 |
6.1 |
5.8 |
14.1 |
13.9 |
5.5 |
|
Vanquis |
106 |
273 |
7.4 |
3.1 |
8.8 |
17.2 |
14.4 |
|
S&U |
2,260 |
282 |
8.7 |
7.7 |
13.2 |
13.9 |
5.9 |
|
Secure Trust Bank |
666 |
125 |
4.0 |
3.1 |
9.5 |
11.2 |
6.3 |
|
Peer average |
956 |
8.1 |
5.9 |
9.7 |
12.4 |
8.1 |
||
Source: Refinitiv, Edison Investment Research. Note: P/E and ROE are calendarized and we use our own estimates for S&U and Secure Trust Bank. Priced 4 September 2023.
Using our assumptions for FY23, STB is currently trading at a diluted P/BV of 0.36x (see Exhibit 7) and P/E of 4.0x. Based on our peer comparison chart, where we use calendarised 2023 P/BV and ROE, STB looks undervalued. On a peer valuation comparison, STB should be trading closer to c 0.6x P/BV or c 1,000p/share. This implies an upside of c 50% from the current share price. Management targets an ROE of 14–16% in the medium term and should this come to fruition, we would expect STB to trade closer to book value.
|
Exhibit 7: Peer group P/BV multiples versus ROE based on FY23 estimates (annualised) |
|
|
Source: Refinitiv, Edison Investment Research. Note: We use our own estimates for S&U (SUS) and STB. MTRO (Metro Bank); VMUK (Virgin Money UK); CBRO (Close Brothers Group); PAGPA (Paragon Banking Group); VANQ (Vanquis Banking Group); OSBO (OneSavings Bank). Priced 4 September 2023. |
Exhibit 8: Financial summary
Year-end December (£m unless stated otherwise) |
2019 |
2020 |
2021 |
2022 |
2023e |
2024e |
Profit and loss |
||||||
Net interest income |
145.4 |
150.9 |
136.2 |
152.6 |
170.4 |
202.4 |
Net commission income |
20.1 |
15.2 |
12.7 |
17.0 |
18.1 |
19.4 |
Total operating income |
165.5 |
166.1 |
148.9 |
169.6 |
188.5 |
221.8 |
Total G&A expenses (excluding non-recurring items below) |
(94.2) |
(92.6) |
(89.4) |
(93.2) |
(101.8) |
(115.3) |
Operating profit pre impairments & exceptionals |
71.3 |
73.5 |
59.5 |
76.4 |
86.7 |
106.5 |
Impairment charges on loans |
(32.6) |
(51.3) |
(5.0) |
(38.2) |
(42.8) |
(51.5) |
Losses on modification of financial assets |
0.0 |
(3.1) |
1.5 |
1.1 |
0.2 |
0.0 |
Non-recurring items and other income |
0.0 |
0.0 |
(0.1) |
(0.3) |
0.9 |
0.0 |
PBT – continuing basis |
38.7 |
19.1 |
55.9 |
39.0 |
45.0 |
55.0 |
Corporation taxes |
(7.6) |
(3.7) |
(10.4) |
(9.4) |
(11.2) |
(13.7) |
Profit after tax - continuing basis |
31.1 |
15.4 |
45.5 |
29.6 |
33.7 |
41.2 |
PBT - discontinued businesses |
0.0 |
0.0 |
0.1 |
5.0 |
(2.0) |
0.0 |
Tax on discontinued businesses |
0.0 |
0.0 |
0.0 |
(0.9) |
0.5 |
0.0 |
PBT - total reported |
38.7 |
19.1 |
56.0 |
44.0 |
43.0 |
55.0 |
Profit after tax - total reported |
31.1 |
15.4 |
45.6 |
33.7 |
32.2 |
41.2 |
Minority interests |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Net attributable income |
31.1 |
15.4 |
45.6 |
33.7 |
32.2 |
41.2 |
Tax rate |
20% |
19% |
19% |
24% |
25% |
25% |
Average basic number of shares in issue (m) |
18.5 |
18.6 |
18.6 |
18.7 |
18.7 |
18.7 |
Average diluted number of shares in issue (m) |
18.7 |
19.0 |
19.0 |
19.3 |
19.2 |
19.2 |
Basic reported EPS (p) |
168.7 |
82.7 |
244.7 |
180.5 |
172.3 |
220.5 |
Reported diluted EPS (p) |
166.7 |
81.0 |
239.4 |
174.7 |
168.0 |
214.9 |
Ordinary DPS (p) |
87.2 |
44.0 |
61.1 |
45.1 |
42.0 |
53.7 |
Net interest/average loans |
6.44% |
6.32% |
5.57% |
5.60% |
5.41% |
5.68% |
Cost of risk |
1.4% |
2.3% |
0.1% |
1.4% |
1.4% |
1.4% |
Cost income ratio |
56.9% |
55.8% |
60.0% |
55.0% |
54.0% |
52.0% |
Balance sheet |
||||||
Net customer loans |
2,450.1 |
2,358.9 |
2,530.6 |
2,919.5 |
3,380.0 |
3,745.0 |
Other assets |
230.6 |
302.3 |
355.1 |
460.3 |
505.1 |
535.0 |
Total assets |
2,680.7 |
2,661.2 |
2,885.7 |
3,379.8 |
3,885.1 |
4,280.0 |
Total customer deposits |
2,020.3 |
1,992.5 |
2,103.2 |
2,514.6 |
2,864.4 |
3,200.9 |
Other liabilities |
408.4 |
401.1 |
480.3 |
538.8 |
668.4 |
695.7 |
Total liabilities |
2,428.7 |
2,393.6 |
2,583.5 |
3,053.4 |
3,532.8 |
3,896.5 |
Net assets |
252.0 |
267.6 |
302.2 |
326.4 |
352.3 |
383.5 |
Minorities |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Shareholders' equity |
252.0 |
267.6 |
302.2 |
326.4 |
352.3 |
383.5 |
Other selected data and ratios |
||||||
NAV per share (p) |
1,364 |
1,438 |
1,622 |
1,748 |
1,884 |
2,051 |
Tangible NAV per share (p) |
1,315 |
1,396 |
1,584 |
1,713 |
1,849 |
2,016 |
Return on average equity |
12.7% |
5.9% |
16.0% |
10.7% |
9.5% |
11.2% |
Return on average TNAV |
14.8% |
6.4% |
18.6% |
11.4% |
11.9% |
14.4% |
Average loans |
2,258.9 |
2,389.0 |
2,444.8 |
2,725.1 |
3,149.8 |
3,562.5 |
Average deposits |
1,967.8 |
2,010.3 |
2,002.8 |
2,308.9 |
2,689.5 |
3,032.6 |
Loans/deposits |
121% |
118% |
120% |
116% |
118% |
117% |
Risk exposure |
2,118.1 |
1,999.7 |
2,087.4 |
2,335.0 |
2,752.7 |
3,079.1 |
Common equity tier 1 ratio |
12.6% |
14.0% |
14.5% |
14.0% |
12.4% |
12.0% |
Source: Secure Trust Bank, Edison Investment Research
|
|
Research: Healthcare
IRLAB has reported its Q223 results, including a recap of clinical activities and financials. IRLAB shared a full analysis of the mesdopetam Phase IIb trial data, and noted the company’s focus on preparing for its FDA end-of-Phase II meeting after securing full rights to the project (previously out-licensed to Ipsen). In addition to the FDA preparations, IRLAB will maintain a flurry of clinical activity, including the anticipated release of top-line results for the Phase IIb pirepemat trial (H124) and potential promotion of up to three preclinical assets (to Phase I-ready status) from H223–FY24. At the end of the quarter, IRLAB had a net cash position of SEK156.4m, supporting a runway through H124. Based on net cash and the anticipated activities, we value IRLAB at SEK4.47bn or SEK86.1/share.